J
Jake D. Jones Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
10 h-index
36 pubs
565 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Jake D. Jones' research focuses on the application of computational methods and advanced imaging techniques to study biological systems, particularly concerning skin and immune responses. He has investigated the quantification of collagen microstructure during mechanical loading of skin and explored age-related changes in skin structure and function using multiscale imaging. His work also involves developing computational tools, such as convolutional neural networks, for automated extraction of biomarkers from skin wound healing using in vivo label-free multiphoton microscopy.
Jones has co-authored publications on vaccine studies, evaluating the safety, immunogenicity, and reactogenicity of pneumococcal and meningococcal vaccines in various age groups. His academic contributions are reflected in his h-index of 10 and 553 total citations across 37 publications. He collaborates with several faculty members at the University of Arkansas at Fayetteville, including Kyle P. Quinn, Alan E. Woessner, Marcos R. Rodriguez, and Michael J. Blair.
Metrics
- h-index: 10
- Publications: 36
- Citations: 565
Selected Publications
-
Understanding Skin Wound Healing Dynamics Through AI-Powered Analysis of Label-free Multiphoton Imaging (2025)
-
Quantification of age-related changes in the structure and mechanical function of skin with multiscale imaging (2024)
-
Quantifying age-related changes in the structure and mechanical function of skin with multiscale imaging (2022)
-
Multimodal characterization of skin wound healing in vivo using label-free multiphoton microscopy (2022)
-
Quantifying 3D tissue kinematics though second harmonic generation microscopy of skin during mechanical loading (2021)
-
Three-Dimensional Quantification of Collagen Microstructure During Tensile Mechanical Loading of Skin (2021)
-
Automated Extraction of Skin Wound Healing Biomarkers From In Vivo Label‐Free Multiphoton Microscopy Using Convolutional Neural Networks (2021)
Collaboration Network
Top Collaborators
Kyle P. Quinn
University of Arkansas at Fayetteville
7 shared publications
In database
- Three-Dimensional Quantification of Collagen Microstructure During Tensile Mechanical Loading of Skin
- Automated Extraction of Skin Wound Healing Biomarkers From In Vivo Label‐Free Multiphoton Microscopy Using Convolutional Neural Networks
- Quantification of age-related changes in the structure and mechanical function of skin with multiscale imaging
- Quantifying age-related changes in the structure and mechanical function of skin with multiscale imaging
- Quantifying 3D tissue kinematics though second harmonic generation microscopy of skin during mechanical loading
Showing 5 of 7 shared publications
Alan E. Woessner
University of Arkansas at Fayetteville
4 shared publications
In database
- Three-Dimensional Quantification of Collagen Microstructure During Tensile Mechanical Loading of Skin
- Quantification of age-related changes in the structure and mechanical function of skin with multiscale imaging
- Quantifying age-related changes in the structure and mechanical function of skin with multiscale imaging
- Quantifying 3D tissue kinematics though second harmonic generation microscopy of skin during mechanical loading
Nathan J. Witt
University of Iowa (US)
4 shared publications
- Three-Dimensional Quantification of Collagen Microstructure During Tensile Mechanical Loading of Skin
- Quantification of age-related changes in the structure and mechanical function of skin with multiscale imaging
- Quantifying age-related changes in the structure and mechanical function of skin with multiscale imaging
- Quantifying 3D tissue kinematics though second harmonic generation microscopy of skin during mechanical loading
Edward A. Sander
University of Iowa (US)
4 shared publications
- Three-Dimensional Quantification of Collagen Microstructure During Tensile Mechanical Loading of Skin
- Quantification of age-related changes in the structure and mechanical function of skin with multiscale imaging
- Quantifying age-related changes in the structure and mechanical function of skin with multiscale imaging
- Quantifying 3D tissue kinematics though second harmonic generation microscopy of skin during mechanical loading
Betül Ulukol
Ankara University (TR)
4 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial
- 4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Peter Richmond
Princess Margaret Hospital for Children (AU)
4 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial
- 4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Marcos R. Rodriguez
University of Arkansas at Fayetteville
3 shared publications
In database
- Automated Extraction of Skin Wound Healing Biomarkers From In Vivo Label‐Free Multiphoton Microscopy Using Convolutional Neural Networks
- Multimodal characterization of skin wound healing in vivo using label-free multiphoton microscopy
- Understanding Skin Wound Healing Dynamics Through AI-Powered Analysis of Label-free Multiphoton Imaging
Mark Bloch
3 shared publications
- Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial
- Breadth of immune response, immunogenicity, reactogenicity, and safety for a pentavalent meningococcal ABCWY vaccine in healthy adolescents and young adults: results from a phase 3, randomised, controlled observer-blinded trial
- 4CMenB Breadth of Immune Response, Immunogenicity, and Safety: Results From a Phase 3 Randomized, Controlled, Observer Blind Study in Adolescents and Young Adults
Robert Lupinacci
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
2 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Richard Rupp
The University of Texas Medical Branch at Galveston (US)
2 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Orasri Wittawatmongkol
Mahidol University (TH)
2 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Ron Dagan
Ben-Gurion University of the Negev (IL)
2 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Jon E. Stek
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
2 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Lizbeth Romero
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
2 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Sandra Koseoglu
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
2 shared publications
- A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED)
- 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED)
Similar Researchers
Based on overlapping research topics
Marcos R. Rodriguez
University of Arkansas at Fayetteville
Medical Imaging Techniques and Applications
Advanced Neural Network Applications
Dermatology and Skin Diseases
M. Emre Celebi
University of Central Arkansas
Medical Imaging Techniques and Applications
Advanced Neural Network Applications
Dermatology and Skin Diseases
Jiahui Chen
University of Arkansas at Fayetteville
Medical Imaging Techniques and Applications
Advanced Neural Network Applications
Machine Learning Applications
Tran-Dac-Thinh Phan
University of Arkansas at Fayetteville
Medical Imaging Techniques and Applications
Advanced Neural Network Applications
Dermatology and Skin Diseases
Shake Ibna Abir
Arkansas State University
Medical Imaging Techniques and Applications
Advanced Neural Network Applications
Dermatology and Skin Diseases
Kyle P. Quinn
University of Arkansas at Fayetteville
Medical Imaging Techniques and Applications
Advanced Neural Network Applications
Dermatology and Skin Diseases